Any current/future new fundraising through debt or equity?

Godavari Biorefineries is exploring means of fundraising for its planned investments. The company aims to fund the estimated INR 325 crore capex for bio-based specialty chemicals and ethanol capacity expansion. Discussions with the board are ongoing to identify the best financing options. No specific confirmation yet on whether the fundraising will be through internal accruals, debt, or equity. The company will update when a clear financing plan is finalized.

Any current/future capex/capital investment/strategic investment?

Godavari Biorefineries plans a capital investment of approximately INR 325 crores at current prices. Around 70% of this capex will be directed toward expanding and de-bottlenecking the bio-based specialty chemicals segment. The remaining 30% will be invested in increasing ethanol production capacity. A new 200 KLPD grain-based (maize) distillery is under construction and is expected to commence commercial production by the end of calendar year 2025. The investment aims to support growth pivots in bio-based specialty chemicals and multi-feedstock ethanol production, targeting a 3x increase in E

Future growth expectations in sales/revenue/volumes?

Godavari Biorefineries targets a significant growth pivot by FY '29 with bio-based specialty chemicals achieving EBITDA margins in excess of 15%. The company plans to add 60 million liters of ethanol capacity via a new 200 KLPD grain-based distillery by end of 2025, increasing ethanol production mix and revenue by over INR 400 crores annually. Revenue and EBITDA growth are expected to be incremental starting FY '26, with stronger growth from FY '27 onwards driven by capacity expansions and de-bottlenecks in specialty chemicals and ethanol segments. The ethanol segment is anticipated to s

Future growth expectations in earnings/operating earnings/profits/EPS?

Godavari Biorefineries expects to achieve a peak EBITDA margin exceeding 15% in the biobased specialty chemicals segment by FY '29. The company targets a 3x increase in EBITDA margins by FY '29, driven by expanding ethanol capacity and ramping up bio-based specialty chemical production. Incremental ethanol production from the new 200 KLPD grain-based distillery (maize) is expected to add over INR 400 crores in revenue, improving EBITDA from Q4 FY '26. Growth in EBITDA and revenues will be incremental starting FY '26, with major ramp-up from FY '27 onwards. Seasonality in earnings will reduce a

Godavari Bioref.Q1 FY26Diversified FMCG

Godavari Bioref. Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹227P/E: 41.7Market Cap: ₹1.2K CrSector: Diversified FMCG

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

Godavari Biorefineries targets a significant growth pivot by FY '29 with bio-based specialty chemicals achieving EBITDA margins in excess of 15%.
The company plans to add 60 million liters of ethanol capacity via a new 200 KLPD grain-based distillery by end of 2025, increasing ethanol production mix and revenue by over INR 400 crores annually.
Revenue and EBITDA growth are expected to be incremental starting FY '26, with stronger growth from FY '27 onwards driven by capacity expansions and de-bottlenecks in specialty chemicals and ethanol segments.
The ethanol segment is anticipated to scale up through multi-feedstock facilities (sugarcane juice, molasses, maize), aligning with India's increasing ethanol blending targets (20% achieved ahead of schedule, possibility of 27% blend).
A CAGR or exact growth percentage is not specified yet; updates will be provided as technologies and projects develop further.
Growth drivers include bio-based specialty chemicals expansion, increased ethanol production, and advancements in emerging bio-based platforms like 2G ethanol and cellulose-based products.

Margin guidance

Category 1

Godavari Biorefineries expects to achieve a peak EBITDA margin exceeding 15% in the biobased specialty chemicals segment by FY '29.
The company targets a 3x increase in EBITDA margins by FY '29, driven by expanding ethanol capacity and ramping up bio-based specialty chemical production.
Incremental ethanol production from the new 200 KLPD grain-based distillery (maize) is expected to add over INR 400 crores in revenue, improving EBITDA from Q4 FY '26.
Growth in EBITDA and revenues will be incremental starting FY '26, with major ramp-up from FY '27 onwards.
Seasonality in earnings will reduce as ethanol and specialty chemicals segments grow.
Revenue CAGR and detailed earnings guidance tied to emerging platforms like 2G ethanol and cellulose-based products will be updated as development progresses.
The company anticipates improved profitability with ongoing de-bottlenecking and capacity expansion, with strategic investments around INR 325 crores planned.

See what Godavari Bioref. management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

Godavari Biorefineries is exploring means of fundraising for its planned investments.
The company aims to fund the estimated INR 325 crore capex for bio-based specialty chemicals and ethanol capacity expansion.
Discussions with the board are ongoing to identify the best financing options.
No specific confirmation yet on whether the fundraising will be through internal accruals, debt, or equity.
The company will update when a clear financing plan is finalized.

Order book

The transcript does not explicitly mention specific details about the current or expected order book or pending orders for Godavari Biorefineries Limited. However, relevant insights include: - The biobased specialty chemicals segment is experiencing strong demand, prompting capacity expansion and de-bottlenecking. - There is active collaboration with Indian and global customers to co-create bio-based chemical solutions, indicating ongoing commercial engagements. - The upcoming 200 KLPD grain-based ethanol distillery is progressing ahead of schedule, with commercial production expected by end of 2025, suggesting future order fulfillment capacity. - The company is involved in technology development stages (e.g., 2G ethanol pipeline in research phase), so related orders or contracts may be in early or future stages. - Efforts are ongoing to optimize multi-feedstock ethanol production, supporting steady order flow in this segment. No explicit quantified order book or pending order figures are disclosed in the provided pages.

See what Godavari Bioref. management said on order book — free account, 30 seconds.

Capex plans

Yes

Godavari Biorefineries plans a capital investment of approximately INR 325 crores at current prices.
Around 70% of this capex will be directed toward expanding and de-bottlenecking the bio-based specialty chemicals segment.
The remaining 30% will be invested in increasing ethanol production capacity.
A new 200 KLPD grain-based (maize) distillery is under construction and is expected to commence commercial production by the end of calendar year 2025.
The investment aims to support growth pivots in bio-based specialty chemicals and multi-feedstock ethanol production, targeting a 3x increase in EBITDA by FY 2029.
Funding options, including internal accruals and external fundraises, are being explored with the Board to finance these expansions.

Track Godavari Bioref. — get its next earnings analysis in your feed

How does Godavari Bioref. rank vs peers in Diversified FMCG?

Pro feature

ThisGodavari Bioref.

Rev 2Mar 1

See where Godavari Bioref. sits in Diversified FMCGSee which companies these are, and every other name in the sector.Open rankings

How does Godavari Bioref. rank in Diversified FMCG?

Compare Godavari Bioref. against every Diversified FMCG company (Q1 FY26) on revenue, margins and earnings-call signals.

View Diversified FMCG leaderboard →

What Godavari Bioref.'s management said in earlier quarters

Others in Diversified FMCG this season

ITC Ltd (Q2 FY25)
1,457 crore (versus Rs. Key concall takeaways from ITC Ltd's Q2 FY25 earnings call — and how it ranks against sector peers.
ITC Ltd (Q3 FY25)
8,344 crore. Key concall takeaways from ITC Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
ITC Ltd (Q4 FY25)
Q4 FY25 Gross Revenue: ₹18,266 crore, up 9.2% YoY (Page 42) . Key concall takeaways from ITC Ltd's Q4 FY25 earnings call — and how it ranks against sector…
ITC Ltd (Q1 FY26)
20,911 crore, up 19.8% YoY (Page 41) . Key concall takeaways from ITC Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.

Compare:vs Hind. Unilever vs ITC Ltd vs Hindustan Foods

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →